Table 2.
Data | Total | Group 1 T2DM | Group 2 Non T2DM | p-value |
---|---|---|---|---|
[N = 1706] | [N = 680] | [N = 1026] | ||
Hemoglobin [mmol/L] | 7.7 ± 1.4 | 7.5 ± 1.5 | 7.9 ± 1.4 | < 0.001 |
Hematocrit [%] | 36 ± 1 | 35 ± 1 | 37 ± 1 | < 0.001 |
Erythrocytes [× 106/μL] | 4.1 ± 0.7 | 4.0 ± 0.7 | 4.1 ± 0.6 | < 0.001 |
Leukocytes [× 103/μL] | 7.3 ± 2.3 | 7.1 ± 2.1 | 7.5 ± 2.4 | < 0.001 |
Platelets [× 103/μL] | 198 ± 64 | 191 ± 65 | 204 ± 63 | < 0.001 |
Total cholesterol [mg/dL] | 198 ± 57 | 179 ± 53 | 210 ± 56 | < 0.001 |
HDL-C [mg/dL] | 52 ± 16 | 49 ± 15 | 53 ± 16 | < 0.001 |
LDL-C [mg/dL] | 121 ± 51 | 103 ± 48 | 132 ± 50 | < 0.001 |
Triglycerides [mg/dL] | 134 ± 79 | 138 ± 76 | 131 ± 81 | 0.001 |
Fasting glucose (mg/dL) | 158 ± 72 | 190 ± 86 | 136 ± 50 | < 0.001 |
Creatinine [mg/dL] | 1.3 ± 0.8 | 1.4 ± 1.0 | 1.2 ± 0.8 | < 0.001 |
eGFR CKD-EPI | 64 ± 23 | 57 ± 23 | 69 ± 21 | < 0.001 |
Max CK-MB level [ng/mL] | 80 ± 104 | 61 ± 89 | 93 ± 112 | < 0.001 |
Max troponin level [pg/mL] | 312 ± 1391 | 186 ± 1106 | 394 ± 1544 | 0.007 |
Data are presented as mean ± SD
(HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, eGFR CKD-EPI estimated glomerular filtration rate Chronic Kidney Disease Epidemiology Collaboration, CK-MB creatine kinase myocardial band isoenzyme)